| Quarter | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| 122 | 313 | 247 | |
Growth YoY Revenue Growth YoY% | 101.9 | ||
| 99 | 197 | 172 | |
| 23 | 116 | 75 | |
OPM OPM% | 18.9 | 37.0 | 30.5 |
| 4 | 13 | 1 | |
Interest Expense Interest ExpenseCr | 7 | 5 | 6 |
Depreciation DepreciationCr | 11 | 11 | 13 |
PBT PBTCr | 9 | 112 | 58 |
| 3 | 30 | 15 | |
| 7 | 82 | 43 | |
Growth YoY PAT Growth YoY% | 541.4 | ||
NPM NPM% | 5.4 | 26.2 | 17.3 |
| 0.7 | 8.1 | 4.2 |
| Quarter | Jun 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| 122 | 313 | 247 | |
Growth YoY Revenue Growth YoY% | 101.9 | ||
| 99 | 197 | 172 | |
| 23 | 116 | 75 | |
OPM OPM% | 18.9 | 37.0 | 30.5 |
| 4 | 13 | 1 | |
Interest Expense Interest ExpenseCr | 7 | 5 | 6 |
Depreciation DepreciationCr | 11 | 11 | 13 |
PBT PBTCr | 9 | 112 | 58 |
| 3 | 30 | 15 | |
| 7 | 82 | 43 | |
Growth YoY PAT Growth YoY% | 541.4 | ||
NPM NPM% | 5.4 | 26.2 | 17.3 |
| 0.7 | 8.1 | 4.2 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Revenue RevenueCr | 468 | 779 | 692 |
Growth Revenue Growth% | 66.5 | -11.2 | |
| 336 | 591 | 504 | |
| 132 | 188 | 188 | |
OPM OPM% | 28.2 | 24.2 | 27.1 |
| 7 | 11 | 20 | |
Interest Expense Interest ExpenseCr | 6 | 15 | 26 |
Depreciation DepreciationCr | 17 | 34 | 47 |
PBT PBTCr | 115 | 151 | 135 |
| 31 | 39 | 37 | |
PAT PATCr | 84 | 112 | 98 |
Growth PAT Growth% | 32.7 | -12.3 | |
NPM NPM% | 18.0 | 14.4 | 14.2 |
| 8.3 | 11.0 | 9.7 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Revenue RevenueCr | 468 | 779 | 692 |
Growth Revenue Growth% | 66.5 | -11.2 | |
| 336 | 591 | 504 | |
| 132 | 188 | 188 | |
OPM OPM% | 28.2 | 24.2 | 27.1 |
| 7 | 11 | 20 | |
Interest Expense Interest ExpenseCr | 6 | 15 | 26 |
Depreciation DepreciationCr | 17 | 34 | 47 |
PBT PBTCr | 115 | 151 | 135 |
| 31 | 39 | 37 | |
PAT PATCr | 84 | 112 | 98 |
Growth PAT Growth% | 32.7 | -12.3 | |
NPM NPM% | 18.0 | 14.4 | 14.2 |
| 8.3 | 11.0 | 9.7 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 2 | 10 | 10 |
Reserves ReservesCr | 138 | 248 | 491 |
| 367 | 247 | 255 | |
| 77 | 128 | 147 | |
| 585 | 632 | 905 | |
| 362 | 311 | 533 | |
| 222 | 321 | 372 | |
| 585 | 632 | 905 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 2 | 10 | 10 |
Reserves ReservesCr | 138 | 248 | 491 |
| 367 | 247 | 255 | |
| 77 | 128 | 147 | |
| 585 | 632 | 905 | |
| 362 | 311 | 533 | |
| 222 | 321 | 372 | |
| 585 | 632 | 905 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 201 | -155 | 28 | |
| -200 | 2 | -103 | |
| 21 | 151 | 70 | |
Net Cash Flow Net Cash FlowCr | 23 | -2 | -5 |
Free Cash Flow Free Cash FlowCr | 135 | -261 | -41 |
CFO To PAT CFO To PAT% | 238.1 | -138.4 | 28.8 |
CFO To EBITDA CFO To EBITDA% | 152.4 | -82.3 | 15.0 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| 201 | -155 | 28 | |
| -200 | 2 | -103 | |
| 21 | 151 | 70 | |
Net Cash Flow Net Cash FlowCr | 23 | -2 | -5 |
Free Cash Flow Free Cash FlowCr | 135 | -261 | -41 |
CFO To PAT CFO To PAT% | 238.1 | -138.4 | 28.8 |
CFO To EBITDA CFO To EBITDA% | 152.4 | -82.3 | 15.0 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|
Market Cap Market CapitalizationCr | 6,535 | |||
Price To Earnings Price To Earnings | 66.5 | |||
Price To Sales Price To Sales | 9.4 | |||
Price To Book Price To Book | 13.0 | |||
EV To EBITDA EV To EBITDA | 34.3 | |||
GPM GPM% | 42.5 | 39.3 | 46.0 | 46.0 |
OPM OPM% | 28.2 | 24.2 | 27.1 | 27.1 |
NPM NPM% | 18.0 | 14.4 | 14.2 | 14.2 |
ROCE ROCE% | 46.8 | 29.5 | 20.4 | 20.4 |
ROE ROE% | 60.1 | 43.5 | 19.6 | 19.6 |
ROA ROA% | 14.4 | 17.7 | 10.8 | 10.8 |
| Financial Year | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|
Market Cap Market CapitalizationCr | 6,535 | |||
Price To Earnings Price To Earnings | 66.5 | |||
Price To Sales Price To Sales | 9.4 | |||
Price To Book Price To Book | 13.0 | |||
EV To EBITDA EV To EBITDA | 34.3 | |||
GPM GPM% | 42.5 | 39.3 | 46.0 | 46.0 |
OPM OPM% | 28.2 | 24.2 | 27.1 | 27.1 |
NPM NPM% | 18.0 | 14.4 | 14.2 | 14.2 |
ROCE ROCE% | 46.8 | 29.5 | 20.4 | 20.4 |
ROE ROE% | 60.1 | 43.5 | 19.6 | 19.6 |
ROA ROA% | 14.4 | 17.7 | 10.8 | 10.8 |
Documents — Kusumgar Ltd
Concall Transcript Summaries — Kusumgar Ltd